Towards Targeted Therapeutics: The Pharmaceutical Industry and Personalized Medicine
View more...
Imaginery Worlds: Reproducibility and Modeled Claims in Precision Medicine
View more...
Glimpsing the future: New immune-based therapies for multiple myeloma.
View more...
Prostate Cancer’s Precision Promise New research is revealing that the genetics of a man’s prostate tumor could dictate the treatments that will save his life
View more...
The mutual benefits of rare disease research and precision medicine
View more...
The Silent Epidemic of Alzheimer’s Disease: Can Precision Medicine Provide Effective Drug Therapies?
View more...
The Computational Network Imaging Frontier: Relevance for Digital Biomarkers in Precision Oncology.
View more...
Diagnosing rare disease
View more...
The Guardian Research Network: A Comprehensive Solution Supporting Adoption of Precision Medicine by the Community
View more...
Clinical Conundrums
View more...
IU announces first round of funding for $300 million Grand Challenges Program

IU announces first round of funding for $300 million Grand Challenges…

INDIANAPOLIS — Indiana University has announced that the Precision Health Initiative, a research initiative focused…

Read More...
Pfizer’s next-generation drug shows promise in ALK/ROS1-positive lung cancer trials

Pfizer’s next-generation drug shows promise in ALK/ROS1-positive…

Chicago, IL – Pfizer Inc. has reported encouraging new data from a Phase 1/2 study of its next-generation ALK/ROS1 tyrosine…

Read More...
Foundation One Data Supports Genomic Profiling to Inform Breast Cancer Treatment Decisions

Foundation One Data Supports Genomic Profiling to Inform Breast…

Cambridge, MA – Foundation Medicine, Inc. recently presented new clinical data communicating the importance of precision…

Read More...
Open Source Health launches precision medicine platform for women

Open Source Health launches precision medicine platform for…

Toronto, Canada – On June 10th Open Source Health launched its cloud-based service developed specifically for women dubbed…

Read More...
Freenome Raises $5.6M in Seed Funding Round

Freenome Raises $5.6M in Seed Funding Round

Philadelphia, PA – Freenome has announced a successful round of seed funding to the sum of $5.6 million. The round was…

Read More...
Breath Test Can Detect Returning Lung Cancer Earlier

Breath Test Can Detect Returning Lung Cancer Earlier

Chicago, IL – The presence of certain volatile organic compounds (VOCs) in the breath can identify the presence of lung…

Read More...
Home Page Ad #2

Video

Precision Medicine at Notre Dame

Notre Dame building a premier precision medicine group...

Read More...

The Power of Research

Cancer Research UK - bringing the power of research to everyone...

Read More...

Value of Medical Innovation

Medical innovation is a virtuous cycle that relies on investments from all stakeholders, patient access to treatment, and…

Read More...

Biogen Idec is Biogen, Once Again

One of the original biotech companies, Biogen has been anchored in Cambridge, MA for nearly four decades. Today, we remain…

Read More...

Novartis Targets Cancer Genomics for Precision Medicine

Go behind the scenes of the Next Generation Diagnostics group at the Novartis Institutes for BioMedical Research, and learn…

Read More...

Early Diagnosis of Genetic Diseases

Parabase Genomics is a privately held molecular diagnostics company focused on changing the way newborns and children with…

Read More...

 Tweets

 Blogs

Real “health care” happens when telemedicine is closely joined to a connected-care delivery model...

What are the factors driving change within the Autoimmune Disease IVD market? Autoimmune diseases...

As scientific progression continues its march forward, the word ‘separation’ is something that we...

Home Page Ad #3